eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 03/02/2012
SPC Apidra 100 U/ml solution for injection in OptiClik cartridge system

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03/02/2012 and displayed until Current
Reasons for adding or updating:
  • Removal of one or more presentations from joint SPC following discontinuation
Date of revision of text on the SPC:   05-Sep-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Product discontinued, but record added back onto eMC until expiry date of last batch supplied
Updated on 25/09/2006 and displayed until 03/02/2012
Reasons for adding or updating:
  • New SPC for new product
  • SPC Submitted in error

Active Ingredients/Generics

 
   insulin glulisine